Skip to main
JNJ

JNJ Stock Forecast & Price Target

JNJ Analyst Ratings

Based on 19 analyst ratings
Buy
Strong Buy 32%
Buy 32%
Hold 37%
Sell 0%
Strong Sell 0%

Bulls say

Johnson & Johnson is well-positioned for future growth with a diverse portfolio and focus on innovative medicine and medtech. The company's strong pipeline and global expansion plans, in addition to commitment to shareholder returns and sustainability, make it an attractive investment option. However, competition and drug pricing reform may present challenges for JNJ.

Bears say

Johnson & Johnson is currently facing a challenging legal landscape due to ongoing litigation related to talc powder and opioid products. The company's restructurings and divestment of its consumer business may also impact its financials in the short term. Additionally, the slow pace of new product launches in its innovative medicine and medtech divisions may limit potential upside to current estimates. Overall, the company's current growth drivers and product pipeline may not be strong enough to counteract these headwinds, leading to a negative outlook.

JNJ has been analyzed by 19 analysts, with a consensus rating of Buy. 32% of analysts recommend a Strong Buy, 32% recommend Buy, 37% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Johnson & Johnson and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Johnson & Johnson (JNJ) Forecast

Analysts have given JNJ a Buy based on their latest research and market trends.

According to 19 analysts, JNJ has a Buy consensus rating as of Sep 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $265.74, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $265.74, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Johnson & Johnson (JNJ)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.